Cargando…

Association of genetic polymorphism of interleukin-17A & interleukin-17F with susceptibility of psoriasis

BACKGROUND & OBJECTIVES: Psoriasis is a chronic inflammatory skin disease with unknown aetiology. So far studies have confirmed that interleukins, pro-inflammatory factors and T-cell activation play major role in the development of disease. Interleukin-17 (IL-17) a T helper inflammatory cytokine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaur, Rajinder, Rawat, Arun Kumar, Kumar, Sunil, Aadil, Wani, Akhtar, Tahseena, Narang, Tarun, Chopra, Dimple
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362716/ https://www.ncbi.nlm.nih.gov/pubmed/30666004 http://dx.doi.org/10.4103/ijmr.IJMR_1859_16

Ejemplares similares

Association of interleukin-4 and interleukin-17F polymorphisms in periodontitis in Dravidian ethnicity
por: Jain, Nidhi, et al.
Publicado: (2013)

Targeting of interleukin-17 in the treatment of psoriasis
por: Lønnberg, Ann Sophie, et al.
Publicado: (2014)

Interleukin-17A and Keratinocytes in Psoriasis
por: Furue, Masutaka, et al.
Publicado: (2020)

The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis
por: Schön, Michael P., et al.
Publicado: (2018)

Out of the shadow of interleukin-17A: the role of interleukin-17F and other interleukin-17 family cytokines in spondyloarthritis
por: Yeremenko, Nataliya
Publicado: (2021)

Serum interleukin 17A and interleukin 17F in children with inflammatory bowel disease
por: Krawiec, Paulina, et al.
Publicado: (2020)

Impact of Adalimumab Treatment on Interleukin-17 and Interleukin-17 Receptor Expression in Skin and Synovium of Psoriatic Arthritis Patients with Mild Psoriasis
por: Bolt, Janne W., et al.
Publicado: (2022)

Interleukin-17 Genes Polymorphisms are Significantly Associated with Cutaneous T-cell Lymphoma Susceptibility
por: KOŁKOWSKI, Karol, et al.
Publicado: (2022)

Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities
por: Menter, Alan, et al.
Publicado: (2021)

Association between Polymorphisms in Interleukin-17A and -17F Genes and Chronic Periodontal Disease
por: Corrêa, Jôice Dias, et al.
Publicado: (2012)

The IL17F His161Arg polymorphism, a potential risk locus for psoriasis, increases serum levels of interleukin-17F in an Asian population
por: Choi, Byung Gon, et al.
Publicado: (2019)

Association of Interleukin-17F gene polymorphisms with susceptibility to severe enterovirus 71 infection in Chinese children
por: Li, Fei, et al.
Publicado: (2018)

Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)
por: Cauli, Alberto, et al.
Publicado: (2015)

Secukinumab - First in Class Interleukin-17A Inhibitor for the Treatment of Psoriasis
por: Godse, Kiran
Publicado: (2017)

Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors
por: Fieldhouse, Keira A, et al.
Publicado: (2020)

Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis
por: PHAN, Céline, et al.
Publicado: (2020)

Correlation between Interleukin-17 gene polymorphism and osteoarthritis susceptibility in Han Chinese population
por: Bai, Yuming, et al.
Publicado: (2019)

The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients
por: Lemancewicz, Dorota, et al.
Publicado: (2012)

Interleukin-17A and interleukin-23 in morphea
por: Dańczak-Pazdrowska, Aleksandra, et al.
Publicado: (2012)

Interleukin-17 Gene Polymorphisms Contribute to Cancer Risk
por: Niu, Yu-Ming, et al.
Publicado: (2014)

The Influence of Interleukin 17A and IL17F Polymorphisms on Chronic Periodontitis Disease in Brazilian Patients
por: Zacarias, Joana Maira Valentini, et al.
Publicado: (2015)

Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study
por: Avallone, Gianluca, et al.
Publicado: (2023)

Association between interleukin-17A/F single nucleotide polymorphisms and susceptibility to osteoarthritis in a Chinese population
por: Jiang, Lifeng, et al.
Publicado: (2019)

Genetic association between interleukin-17 and susceptibility to rheumatoid arthritis
por: Zhao, Rong, et al.
Publicado: (2023)

Association of interleukin-17A rs2275913 polymorphism with rheumatoid arthritis susceptibility in Sudanese population
por: Osman, Rgda Mohamed, et al.
Publicado: (2021)

Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
por: Yajima, Makiko, et al.
Publicado: (2019)

Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
por: Sánchez-Dueñas, Luis E., et al.
Publicado: (2020)

The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis
por: Egeberg, A., et al.
Publicado: (2020)

Interleukin-17 cytokines: Effectors and targets in psoriasis—A breakthrough in understanding and treatment
por: Prinz, Immo, et al.
Publicado: (2019)

Interleukin-17 Links Inflammatory Cross-Talks Between Comorbid Psoriasis and Atherosclerosis
por: Wang, Yan, et al.
Publicado: (2022)

Association of Interleukin-17F Polymorphism and Mortality Predictors with the Risk of COVID-19
por: El-Desoky, Manal M., et al.
Publicado: (2022)

Targeting interleukin-17 receptors
por: Lee, Wen-Hwa, et al.
Publicado: (2015)

Roles of interleukin-17 in uveitis
por: Guedes, Marta Catarina Esteves, et al.
Publicado: (2016)

Interleukin-17 in Antifungal Immunity
por: Sparber, Florian, et al.
Publicado: (2019)

Interleukin 35 regulates interleukin 17 expression and T helper 17 in patients with proliferative diabetic retinopathy
por: Yan, Ai, et al.
Publicado: (2022)

Association of interleukin-17A gene promoter polymorphism with the susceptibility to generalized chronic periodontitis in an Iranian population
por: Malvandi, Mahdieh, et al.
Publicado: (2022)

Interleukin-17 and Interleukin-10 Association with Disease Progression in Schizophrenia
por: Chenniappan, Raghavi, et al.
Publicado: (2020)

Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases
por: Wasilewska, Agnieszka, et al.
Publicado: (2016)

Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis
por: Rongioletti, Franco, et al.
Publicado: (2018)

Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist
por: Li, Qingran, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hoskutdgldtgi1osdpqf97sgbr